Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Wise, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wise, R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (2000) 46, 1-2
© 2000 The British Society for Antimicrobial Chemotherapy

Introduction

R. Wise*

Department of Microbiology, City Hospital Trust, Birmingham, UK


   Introduction
 
From the perspective of antimicrobial chemotherapy, certain parallels are apparent between the advances we are witnessing in the development of fluoroquinolones and those we have seen in the ß-lactams. From parent compounds such as penicillin or 7-amino cephalosporanic acid, agents have been developed with enhanced antibacterial spectra and clinical uses have changed beyond . . . [Full Text of this Article]


   Notes
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Clin. Microbiol.Home page
M. A. Pfaller, D. J. Diekema, S. A. Messer, L. Boyken, and R. J. Hollis
Activities of Fluconazole and Voriconazole against 1,586 Recent Clinical Isolates of Candida Species Determined by Broth Microdilution, Disk Diffusion, and Etest Methods: Report from The ARTEMIS Global Antifungal Susceptibility Program, 2001
J. Clin. Microbiol., April 1, 2003; 41(4): 1440 - 1446.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
I. Wiedemann, E. Breukink, C. van Kraaij, O. P. Kuipers, G. Bierbaum, B. de Kruijff, and H.-G. Sahl
Specific Binding of Nisin to the Peptidoglycan Precursor Lipid II Combines Pore Formation and Inhibition of Cell Wall Biosynthesis for Potent Antibiotic Activity
J. Biol. Chem., January 12, 2001; 276(3): 1772 - 1779.
[Abstract] [Full Text] [PDF]